Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for PD 1
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
- L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
Most Relevant Literature
- The association between PD-1 gene polymorphisms and susceptibility to multiple sclerosis.
- The immune checkpoint protein PD-1: Its emerging regulatory role in memory T cells.
- Transcriptomic profiling of programmed cell death 1 (PD-1) expressing T cells in early rheumatoid ar…
- Sex-Specific Associations Between Susceptibility to Mycobacterium avium Complex Lung Disease and Pro…
- PD-1: A New Candidate Target for Analgesic Peptide Design.
Most Relevant Clinical Trials
- Duration of Anti-PD-1 Therapy in Metastatic Melanoma
- Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyng…
- SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Contro on PD-1/PDL-1 Tx
- Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSC…
- Decitabine and Anti-PD-1 in R/R DLBCL
